Dr. Reddy's Laboratories Limited has informed the Exchange about sale of wholly owned subsidiary

Core Business DivestedStrategic Transactions View source PDF

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+1.0%1-day move

₹1198.00

prior close

₹1210.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.3-0.2-0.0-0.4+1.0+2.6+3.0+1.9+2.0+2.7+10.6+8.1+6.4+12.8

Up moveDown movePending

AI summary

Dr. Reddy's Laboratories has sold its entire 100% stake in Svaas Wellness Limited, a wholly owned subsidiary, to Enspirit Technology Services Private Limited for INR 2.23 Crore. The transaction was agreed and completed on April 7, 2026. Svaas Wellness had a turnover of Rs. 28.5 Crore in FY 2025, contributing approximately 0.09% to Dr. Reddy's consolidated turnover. The buyer is a non-related party and is not part of the promoter or group companies. The transaction does not constitute a related party transaction and is not part of any scheme of arrangement.

Likely market impact

This is a relatively small transaction, representing less than 0.1% of consolidated revenue, so the financial impact on Dr. Reddy's is minimal. It signals a strategic pruning of non-core subsidiaries.